EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Potent reaction hijacking inhibitors of Plasmodium falciparum asparagine tRNA synthetase

Xi Ye, Lisl Y Esherick, Nutpakal Ketprasit iD, Sunil K Narwal, Luiz C Godoy, Nonlawat Boonyalai, Con Dogovski, Craig J Morton, Tayla Rabie, Mufuliat T Famodimu, Chia-Wei Tai, Tomas Yeo und 20 weitere

mBio · 30.10.2026

DOI: 10.1128/mbio.01884-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, online erschienen am 30.10.2026. Verfasst von Xi Ye und 31 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Melbourne, Victoria, A…. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Research Council, Bill and Melinda Gates Foundation, Medicines for Malaria Venture.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Malaria remains one of the major threats to human health. Breakthrough drugs with high potency and low resistance risk are needed to combat the ever-increasing resistance to currently deployed antimalarials. Here, we explore a series of 4-aminoquinazoline-based sulfonamides (4AQS), with a synthetically accessible scaffold. Exemplars exhibit nanomolar potency against blood stage Plasmodium cultures, with up to 300-fold selectivity compared with a mammalian cell line. The compounds are active against transmissible stages of Plasmodium falciparum and refractory to resistance development. Targeted mass spectrometry reveals that the 4AQS compounds act as reaction hijacking inhibitors targeting P. falciparum aminoacyl tRNA synthetases (aaRSs). Subtle changes to the chemical structure switch the main target from cytoplasmic threonine tRNA synthetase ( Pf ThrRS) to cytoplasmic asparagine tRNA synthetase ( Pf AsnRS), a change that is associated with increased potency against P. falciparum . The target preference was confirmed by selective knockdown of different P. falciparum aaRSs and by tolerance selection in a mutator line. Consistent with aaRS targets, exemplar compounds activate the amino acid starvation response. Recombinant enzyme inhibition and thermal stabilization assays confirm the susceptibility of Pf AsnRS to reaction hijacking and show that human AsnRS is less susceptible. A molecular model of Asn-tRNA-bound Pf AsnRS reveals that a potent hijacker adopts a pose similar to adenosine 5′-monophosphate (AMP). An AlphaFold model of the native Pf AsnRS dimer helps explain the tolerance-conferring effect of a mutation at the dimer interface. IMPORTANCE Every year, at least 200 million new malaria infections are diagnosed, causing more than 600,000 deaths in Africa and Southeast Asia. Ever-increasing levels of resistance to current antimalarials are leading to an impending crisis. Breakthrough drugs with new modes of action are much needed. Here, we explore a series of inhibitors that hijack critical malaria parasite enzymes. The target enzymes catalyze the formation of a bond between the hijackers and an enzyme substrate, forming a tight-binding compound that disrupts the malaria parasite’s protein translation machinery. The hijacking inhibitors exhibit high-level potency against the disease-causing stage of the malaria parasite and are also active against transmissible stages. They exhibit up to 300-fold selectivity compared with a mammalian cell line, possess drug-like chemical attributes, and are easily synthesized. Importantly, the compounds are refractory to resistance development.

Schlagwörter

Stichwörter der Autor:innen

aminoacyl tRNA synthetaseantimalarial drugsmalariamechanism of actionmechanisms of resistancereaction hijacking

Autor:innen und Institutionen

  • Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Melbourne, Victoria, Australia.
  • Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
  • Department of Microbiology and Immunology, Columbia University Medical Center, New York, New York, USA.
  • Biological Chemistry and Drug Discovery, Faculty of Life Sciences, University of Dundee, Dundee, United Kingdom.
  • Drug Delivery Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
  • Biotherapeutics Program CSIRO, Clayton South, Australia.

ORCID-Profile: Nutpakal Ketprasit, Darren J Creek, Marcus C S Lee, Miles G Siegel, Leann Tilley, Stanley C Xie

Förderung

  • Australian Research Council
  • Bill and Melinda Gates Foundation
  • Medicines for Malaria Venture
  • Foundation for the National Institutes of Health
  • UKRI Medical Research Council
  • National Health and Medical Research Council

Zitieren

APA

Ye, X., Esherick, L. Y., Ketprasit, N., Narwal, S. K., Godoy, L. C., Boonyalai, N., Dogovski, C., Morton, C. J., Rabie, T., Famodimu, M. T., Tai, C. W., Yeo, T., Donnelly, O., Orta, L. V., Anderson, I., Jeon, J. H., Le, L. H. M., Leeming, M. G., Laureano De Souza, M., …, & Xie, S. C. (2026). Potent reaction hijacking inhibitors of Plasmodium falciparum asparagine tRNA synthetase. mBio. https://doi.org/10.1128/mbio.01884-26

Vancouver

Ye X, Esherick LY, Ketprasit N, Narwal SK, Godoy LC, Boonyalai N, et al. Potent reaction hijacking inhibitors of Plasmodium falciparum asparagine tRNA synthetase. mBio. 2026. doi:10.1128/mbio.01884-26

BibTeX
@article{Ye2026,
  author = {Ye, Xi and Esherick, Lisl Y and Ketprasit, Nutpakal and Narwal, Sunil K and Godoy, Luiz C and Boonyalai, Nonlawat and Dogovski, Con and Morton, Craig J and Rabie, Tayla and Famodimu, Mufuliat T and Tai, Chia-Wei and Yeo, Tomas and Donnelly, Owain and Orta, Lily V and Anderson, Isla and Jeon, Jin H and Le, Lena H M and Leeming, Michael G and Laureano De Souza, Mariana and Chenu, Elodie and Creek, Darren J and Delves, Michael J and Birkholtz, Lyn-Marie and Duffy, James and Lobb, Karen and Durst, Greg and Lee, Marcus C S and Fidock, David A and Niles, Jacquin C and Siegel, Miles G and Tilley, Leann and Xie, Stanley C},
  title = {Potent reaction hijacking inhibitors of Plasmodium falciparum asparagine tRNA synthetase},
  journal = {mBio},
  year = {2026},
  doi = {10.1128/mbio.01884-26}
}
Kostenlos starten →